BlackRock »

Vyne Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $156k 83k 1.88

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Vyne Therapeutics

Cormorant Asset Management
Eventide Asset Management
Citadel Advisors
DSC Advisors
Silverarc Capital Management
Palo Alto Investors
Vanguard Group
Exome Asset Management
Parkman Healthcare Partners
AlphaCentric Advisors
Schonfeld Strategic Advisors
Geode Capital Management
Renaissance Technologies
BlackRock
BlackRock

View all funds holding Vyne Therapeutics